AI-Designed Drug AH-001 Complete U.S. Phase I Trial, Demonstrating Excellent Safety and Tolerability

Discovered Therapeutics; Advances Toward Global Licensing and Phase II Development TAIPEI, Oct. 29, 2025 /PRNewswire/ -- AnHorn Medicines, a biotech company leveraging generative AI to design small ...
Boston College

Supporting first-gens

BC F1RST resident Alexandra Kabo ’24, right, talks with Hardey Hall Resident Assistant Idris Council ’22, center, and Resident Director Marco Aurelien. (Peter Julian) For first-generation college ...